AVPR1B and metabolic syndrome: In summary, there appears to be both metabolic (mediated by V1a receptor-induced gluconeogenesis) and central (mediated by activation of V1b receptors and the stress response) mechanisms by which AVP contributes to hyperglycemia and the metabolic syndrome.